Artificial intelligence in COVID-19 drug repurposing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Artificial intelligence in COVID-19 drug repurposing

Published:2020-12 Issue:12 Volume:2 Page:e667-e676
ISSN:2589-7500
Container-title:The Lancet Digital Health
language:en
Short-container-title:The Lancet Digital Health

Author:

Zhou Yadi,Wang Fei,Tang Jian,Nussinov Ruth,Cheng Feixiong

Publisher

Elsevier BV

Subject

Health Information Management,Decision Sciences (miscellaneous),Health Informatics,Medicine (miscellaneous)

Reference79 articles.

1. Computing machinery and intelligence;Turing;Mind,1950

2. How artificial intelligence is changing drug discovery;Fleming;Nature,2018

3. AI-powered drug discovery captures pharma interest;Smalley;Nat Biotechnol,2017

4. The $2·6 billion pill·methodologic and policy considerations;Avorn;N Engl J Med,2015

5. New uses for old drugs;Chong;Nature,2007

Cited by 369 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DrugMAP 2.0: molecular atlas and pharma-information of all drugs;Nucleic Acids Research;2024-09-13

2. Quantitative pulmonary pharmacokinetics of tetrandrine for SARS-CoV-2 repurposing: a physiologically based pharmacokinetic modeling approach;Frontiers in Pharmacology;2024-09-13

3. Advances in the approaches used to repurpose drugs for neuroblastoma;Expert Opinion on Drug Discovery;2024-09-11

4. Blockchain, artificial intelligence, and healthcare: the tripod of future—a narrative review;Artificial Intelligence Review;2024-08-08

5. The future of bone regeneration: Artificial intelligence in biomaterials discovery;Materials Today Communications;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3